Is a complete TSXV/PCRX research report available?

No complete published report is available for tsxv/PCRX (TSXV/PCRX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

tsxv/PCRX stock profile: metrics, valuation and analysis

Market cap	78.3M
Revenue (ttm)	27.4M
Net income (ttm)	-1.1M
EPS (ttm)	-CA$0.01
Shares out	174.1M
P/E (forward)	26.9x
Volume	135,560
Beta	-4.29

All TSXV/PCRX indicators

Market & fundamental data

Available fields

171

Groups with data

Currency

CAD

Showing 171 of 171 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 59.1M
Exchange	TSX Venture Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Pharmaceutical Retailers
Last refreshed	2026-09-11
Market cap	CAD 78.3M
Price	CAD 0.45
Price currency	CAD
Sector	Healthcare
Sic	5912
Symbol	tsxv/PCRX
Website	https://www.pharmacorprx.ca

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1.36%
EV/FCF	1,377.08x
EV/Sales	2.16x
FCF yield	0.05%
Forward P/E	26.95x
P/B ratio	1.47x
P/S ratio	2.86x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-4.79%
EBITDA Margin	-0.95%
FCF margin	0.16%
Gross margin	39.53%
Gross Profit	CAD 10.8M
Gross Profit Growth	98.49%
Gross Profit Growth Q	78.21%
Net Income	CAD -1.1M
Net Income Growth Qo Q	-72.04%
Pretax Margin	-2.81%
Profit Margin	-3.89%
ROA	-1.65
ROCE	-2.17
ROE	-2.51
ROIC	-3.89

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-4.17%
Cagr3y	29.86%
EPS Growth Qo Q	-71.99
FCF Growth	-87.66%
OCF Growth	-43.11%
Revenue Growth	97.1x
Revenue Growth Q	75.81x
Revenue Growth Qo Q	7.51x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.55
Assets	CAD 64.3M
Cash	CAD 24M
Current Assets	CAD 28.9M
Current Liabilities	CAD 3.9M
Debt	CAD 4.4M
Debt Equity	CAD 0.08
Debt FCF	CAD 103
Equity	CAD 53.2M
Interest Coverage	-10.02
Liabilities	CAD 11.2M
Long Term Assets	CAD 35.5M
Long Term Liabilities	CAD 7.3M
Net Cash	CAD 19.6M
Net Cash By Market Cap	CAD 25
Net Cash Growth	125.53%
Net Debt Equity	CAD -0.37
Net Debt FCF	CAD -456
Tangible Book Value	CAD 22.7M
Tangible Book Value Per Share	CAD 0.13
WACC	-18.16

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.36
Inventory Turnover	6.88
Net Working Capital	CAD 1.5M
Quick ratio	6.53
Working Capital	CAD 24.9M
Working Capital Turnover	CAD 1.58

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-31.9%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-4.17%
200-day SMA	0.47
3Y total return	119.05%
50-day SMA	0.5
50-day SMA vs 200-day SMA	50over200
All Time High	0.88
All Time High Change	-47.43%
All Time High Date	2024-08-28
All Time Low	0.12
All Time Low Change	283.33%
All Time Low Date	2022-09-29
ATR	0.01
Beta	-4.29
Beta1y	-0.14
Beta2y	0.3
Ch YTD	1.1
High	0.46
High52	0.58
High52 Date	2026-07-06
High52ch	-22.41%
Low	0.45
Low52	0.4
Low52 Date	2025-12-09
Low52ch	12.5%
Ma50ch	-7.3%
Price vs 200-day SMA	-1.18%
RSI	35.69
RSI Monthly	54.78
RSI Weekly	44.39
Sharpe ratio	0.08x
Sortino ratio	0.24
Total Return	-31.9%
Tr YTD	1.1
Tr1m	-8%
Tr1w	0%
Tr3m	-8%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	155,522,946%
Net Borrowing	2,794,868
Shares Insiders	10.66%
Shares Institutions	6.23%
Shares Out	174,081,659
Shares Qo Q	-0.07%
Shares Yo Y	31.9%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD -418,048
Adjusted OCF	-231,450
Average Volume	159,712.1x
Bv Per Share	0.3
CAPEX	CAD -186,598
Ch1m	-8
Ch1w	0
Ch1y	-4.17
Ch3m	-8
Ch3y	119
Ch6m	5.75
Change	-2.17%
Change From Open	-1.1
Close	0.46
Days Gap	-1.09
Depreciation Amortization	1,050,815
Dollar Volume	61,002
Earnings Date	2026-11-18
EBIT	CAD -1.3M
EBITDA	CAD -261,541
EPS	CAD -0.01
F Score	5
FCF	CAD 42,948
FCF EV Yield	0.07x
FCF Per Share	CAD 0
Financing CF	25,264,440
Fiscal Year End	December
Founded	2,021
Goodwill	18,612,463
Income Tax	CAD 279,332
Investing CF	-11,042,898
Is Primary Listing	1
Last Earnings Date	2026-02-26
Last Report Date	2026-06-30
Ma150	0.47
Ma150ch	-2.54%
Ma20	0.49
Ma20ch	-5.23%
Net CF	14,451,088
Next Earnings Date	2026-11-18
Open	0.46
P FCF Ratio	1,824
P OCF Ratio	341.3
Position In Range	0
Ppne	5,402,922
Price Date	2026-09-10
Ptbv Ratio	3.45
Relative Volume	0.85x
Revenue	27,408,416x
SBC By Revenue	1.68x
Share Based Comp	460,996
Tax By Revenue	1.02x
Tr6m	5.75%
Volume	135,560
Z Score	4.52

TSXV/PCRX (TSXV/PCRX)

Price

Financial snapshot

Fair-value bridge

Latest news · TSXV/PCRX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSXV/PCRX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on TSXV/PCRX

Frequently asked questions